25
Apr
2018

What Can You Do With Genomics and AI? Alice Zhang on The Long Run

Today’s guest on The Long Run podcast is Alice Zhang.

Alice Zhang, co-founder and CEO, Verge Genomics

Let’s start with some basic background. Zhang studied systems biology at Princeton, graduated with honors, enrolled in an MD/PHD program at UCLA/Caltech, stayed there five years, quit, moved to Silicon Valley, and co-founded a company dedicated to using her knowledge for neurodegenerative drug discovery. She has been named among the Forbes 30-under-30.  

You get the idea. She’s smart. And young.

That’s nice, but what makes her more interesting to me as a guest for this show is her thoughtful approach to combining genomic data with artificial intelligence to improve drug discovery for complex multifactorial diseases. Specifically, the neurodegenerative kind. There are people out there thumping the tub, and drinking the AI Kool Aid, but I think Zhang has a pretty wise sense for what the AI can and can’t do. I learned a few things listening to her, and I think you will too.

You may also like

Google Money at Work in Biology: Krishna Yeshwant on The Long Run
Extending Human Healthspan: Ned David of Unity Biotech on The Long Run
From Nova Scotia to the Forefront of Bio & Tech Investing: Julie Sunderland of Biomatics on The Long Run
Exploring Synthetic Lethal Cancer Drug Discovery: Barbara Weber on The Long Run